Daiichi Sankyo Company, Limited (4568.T) PEG Ratio

Potentially Undervalued

PE ratio relative to earnings growth — is the valuation justified?

0.66

PEG Ratio

0.66

Growth Rate Source

Good Data Quality5-Year EPS CAGR

Current Price

$2700.50

TTM EPS

$140.34

P/E Ratio

19.24

Growth Rate

29.1%

5-Year EPS CAGR

Sector

Healthcare

Drug Manufacturers - General

Calculated

7/20/2026

11:58:45 PM

Peer Comparison

Sample Size

3 peers

Industry Median PEG

0.85

25th Percentile

0.70

75th Percentile

1.90

4568.T PEG (0.66) vs Industry Median (0.85): 22% discount

Symbol	Company	PEG	P/E	Growth	vs 4568.T
4503.T	Astellas Pharma Inc.	0.70	14.1	20.2%	+5%
4507.T	Shionogi & Co., Ltd.	0.85	12.4	14.7%	+28%
4519.T	Chugai Pharmaceutical Co., Ltd.	1.90	28.7	15.1%	+188%

How to Interpret PEG Ratio

PEG < 1.0 — Potentially Undervalued. The stock may be priced below its earnings growth rate, suggesting a potential buying opportunity.

PEG 1.0–2.0 — Fairly Valued. The stock price is roughly in line with its earnings growth. A PEG of 1.0 is often considered "fair value."

PEG > 2.0 — Potentially Overvalued. The stock may be priced above what its earnings growth justifies.

Limitations:PEG ratios are less reliable for financial firms (earnings driven by interest margins), companies with negative/zero earnings growth, and hypergrowth companies (>100% growth) where the ratio may appear misleadingly low. Always use PEG alongside other valuation metrics.

Daiichi Sankyo Company, Limited (4568.T) PEG Ratio

Peer Comparison

How to Interpret PEG Ratio

More on 4568.T

Compare with peers

Explore

Daiichi Sankyo Company, Limited (4568.T) PEG Ratio

Peer Comparison

How to Interpret PEG Ratio

More on 4568.T

Compare with peers

Explore